- 5 次围观
产品图片
![BEI Resources生物材料图片 BEI Resources生物材料图片](/sites/default/files/Data96/Beiresource_product_image_sample.jpg)
货号/SKU
NR-4057
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、1
产品描述信息
NR-4057?? Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins (Peptides and Peptide Arrays)|Vaccinia virus|Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins |-20°C|NIH Biodefense and Emerging Infections Research Resources RepositoryAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Peptide Arrays, HLA Supertype A and B Epitopes of Vaccinia Virus Proteins, NR-4057."|Quantity Limit per Order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
NR-4057 contains six peptide arrays. The first peptide array (NRC-415; 12 peptides) consists of HLA supertype A1 epitopes of the vaccinia virus proteins: C19L, C10L, C10L, C12L, VWR050, D1R, D12L, B8R, B8R, B8R variant, B8R, and C19L. The second peptide array (NRC-416; 34 peptides) consists of HLA supertype A2 epitopes of the vaccinia virus proteins: C7L, N2L, F12L, F12L, VACWR082, E2L, E9L, O1L, I4L, A6L, D3R, A26L, A36R, A36R variant, A55R, A14L, I1L, A46R, A17L, H3L, B14R, B14R variant, A6L, D12L, G7L, VACWR050, M1L, A17L, B6R, VETFsm, A26L, A26L variant, B22R & C16L, and B22R & C16L variant. The third peptide array (NRC-417; 17 peptides) consists of HLA supertype A3 epitopes of the vaccinia virus proteins: C12L, C9L, C7L, C5L, I3L, G8R, J6R, D1R, D5R, D5R variant, A8R, A31R, A31R variant, A31R variant, B5R, B14R, and B14R variant. The fourth peptide array (NRC-418; 5 peptides) consists of HLA supertype A24 epitopes of the vaccinia virus proteins: D5R, D5R, D5R variant, C6L, and C6L variant. The fifth peptide array (NRC-419; 8 peptides) consists of HLA supertype B7 epitopes of the vaccinia virus proteins: C1L, C1L variant, F4L, F4L variant, O1L, J6R, D1R, and D1R variant. The sixth peptide array (NRC-420; 6 peptides) consists of HLA supertype B44 epitopes of the vaccinia virus proteins: C3L, C3L variant, C3L variant, G2R, G2R variant, and B8R. Peptides are 9- to 10-mers.
Peptides are provided lyophilized at 1 mg per vial.
NR-4057 contains six peptide arrays. The first peptide array (NRC-415; 12 peptides) consists of HLA supertype A1 epitopes of the vaccinia virus proteins: C19L, C10L, C10L, C12L, VWR050, D1R, D12L, B8R, B8R, B8R variant, B8R, and C19L. The second peptide array (NRC-416; 34 peptides) consists of HLA supertype A2 epitopes of the vaccinia virus proteins: C7L, N2L, F12L, F12L, VACWR082, E2L, E9L, O1L, I4L, A6L, D3R, A26L, A36R, A36R variant, A55R, A14L, I1L, A46R, A17L, H3L, B14R, B14R variant, A6L, D12L, G7L, VACWR050, M1L, A17L, B6R, VETFsm, A26L, A26L variant, B22R & C16L, and B22R & C16L variant. The third peptide array (NRC-417; 17 peptides) consists of HLA supertype A3 epitopes of the vaccinia virus proteins: C12L, C9L, C7L, C5L, I3L, G8R, J6R, D1R, D5R, D5R variant, A8R, A31R, A31R variant, A31R variant, B5R, B14R, and B14R variant. The fourth peptide array (NRC-418; 5 peptides) consists of HLA supertype A24 epitopes of the vaccinia virus proteins: D5R, D5R, D5R variant, C6L, and C6L variant. The fifth peptide array (NRC-419; 8 peptides) consists of HLA supertype B7 epitopes of the vaccinia virus proteins: C1L, C1L variant, F4L, F4L variant, O1L, J6R, D1R, and D1R variant. The sixth peptide array (NRC-420; 6 peptides) consists of HLA supertype B44 epitopes of the vaccinia virus proteins: C3L, C3L variant, C3L variant, G2R, G2R variant, and B8R. Peptides are 9- to 10-mers.
Peptides are provided lyophilized at 1 mg per vial.
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送到NIAID以批准. NR-4057包含六个肽阵列.第一肽阵列(NRC-415; 12肽)由痘苗病毒病毒蛋白的HLA Supertype A1表位组成:C19L,C10L,C10L,C12L,VWR050,D1R,D12L,B8R,B8R,B8R变体,B8R和C19L.第二肽阵列(NRC-416; 34肽)由HLA Supertype A2表位组成的痘苗病毒蛋白质:C7L,N 2L,F12L,F12L,VacWr082,E2L,E9L,O11,I4L,A6L,D3R,A26L,A36R, A36R变体,A55R,A14L,I1L,A46R,A17L,H3L,B14R,B14R变体,A6L,D12L,G7L,VacWr050,M1L,A17L,B6R,Vetfsm,A26L,A26L变体,B22R试验; C16L和B22R试验; C16L变体.第三肽阵列(NRC-417; 17个肽)由HLA Supertype A3表位组成的痘苗病毒蛋白质:C12L,C9L,C7L,C5L,I3L,G8R,J6R,D1R,D5R,D5R变体,A8R,A31R,A31R变体,A31R变量,B5R,B14R和B14R变体.第四肽阵列(NRC-418; 5肽)由HLA Supertype A24表位组成,疫苗病毒蛋白质:D5R,D5R,D5R变体,C6L和C6L变体.第五肽阵列(NRC-419; 8肽)由痘苗病毒蛋白的HLA超型B7表位组成:C1L,C1L变体,F4L,F4L变体,O1L,J6R,D1R和D1R变体.第六肽阵列(NRC-420; 6肽)由痘苗病毒蛋白的HLA Supertype B44表位组成:C3L,C3L变体,C3L变体,G2R,G2R变体和B8R.肽是9-至10mers. 肽在每小时1毫克冻干.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识
![BEI Resources BEI Resources 由美国国家过敏和传染病研究所资助,由 ATCC 管理](/sites/default/files/brand_logo/beiresources_logo.jpg)
可能感兴趣的内容
2024-05-19
2022-04-01
2023-10-24
2022-03-31
2024-01-21
2022-04-01
2021-12-21
2021-10-31
2022-04-01
2022-01-10
2022-04-01
2021-12-21
2021-12-13
2024-06-18
2024-05-19